In our search for promising dietary Nrf2 activators with potential chemopreventive activity targeting CRC we have focused our studies on trans-cinnamic aldehyde (cinnamaldehyde, CA), the key flavor compound in cinnamon essential oil extracted from Cinnamomum zeylanicum and Cinnamomum cassia bark. The gene discussed is NFE2L2; the disease is colorectal carcinoma.